BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 23717423)

  • 1. In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.
    Hwang J; Alemayehu BH; Reithinger R; Tekleyohannes SG; Takele Teshi ; Birhanu SG; Demeke L; Hoos D; Melaku Z; Kassa M; Jima D; Malone JL; Nettey H; Green M; Poe A; Akinyi S; Udhayakumar V; Kachur SP; Filler S
    PLoS One; 2013; 8(5):e63433. PubMed ID: 23717423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial.
    Abreha T; Hwang J; Thriemer K; Tadesse Y; Girma S; Melaku Z; Assef A; Kassa M; Chatfield MD; Landman KZ; Chenet SM; Lucchi NW; Udhayakumar V; Zhou Z; Shi YP; Kachur SP; Jima D; Kebede A; Solomon H; Mekasha A; Alemayehu BH; Malone JL; Dissanayake G; Teka H; Auburn S; von Seidlein L; Price RN
    PLoS Med; 2017 May; 14(5):e1002299. PubMed ID: 28510573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmed vivax resistance to chloroquine and effectiveness of artemether-lumefantrine for the treatment of vivax malaria in Ethiopia.
    Yohannes AM; Teklehaimanot A; Bergqvist Y; Ringwald P
    Am J Trop Med Hyg; 2011 Jan; 84(1):137-40. PubMed ID: 21212216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
    Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand.
    Krudsood S; Tangpukdee N; Muangnoicharoen S; Thanachartwet V; Luplertlop N; Srivilairit S; Wilairatana P; Kano S; Ringwald P; Looareesuwan S
    Korean J Parasitol; 2007 Jun; 45(2):111-4. PubMed ID: 17570973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malaria.
    Bassat Q
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1325. PubMed ID: 22216359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
    Gogtay N; Kannan S; Thatte UM; Olliaro PL; Sinclair D
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008492. PubMed ID: 24163021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia.
    Assefa A; Mohammed H; Anand A; Abera A; Sime H; Minta AA; Tadesse M; Tadesse Y; Girma S; Bekele W; Etana K; Alemayehu BH; Teka H; Dilu D; Haile M; Solomon H; Moriarty LF; Zhou Z; Svigel SS; Ezema B; Tasew G; Woyessa A; Hwang J; Murphy M
    Malar J; 2022 Dec; 21(1):359. PubMed ID: 36451216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.
    Yuan L; Wang Y; Parker DM; Gupta B; Yang Z; Liu H; Fan Q; Cao Y; Xiao Y; Lee MC; Zhou G; Yan G; Baird JK; Cui L
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1230-5. PubMed ID: 25512415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia.
    Hwang J; Alemayehu BH; Hoos D; Melaku Z; Tekleyohannes SG; Teshi T; Birhanu SG; Demeke L; Gobena K; Kassa M; Jima D; Reithinger R; Nettey H; Green M; Malone JL; Kachur SP; Filler S
    Malar J; 2011 Jul; 10():209. PubMed ID: 21798054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed-Dose Artesunate-Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial.
    Siqueira AM; Alencar AC; Melo GC; Magalhaes BL; Machado K; Alencar Filho AC; Kuehn A; Marques MM; Manso MC; Felger I; Vieira JL; Lameyre V; Daniel-Ribeiro CT; Lacerda MV
    Clin Infect Dis; 2017 Jan; 64(2):166-174. PubMed ID: 27988484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine-resistant Plasmodium vivax malaria in Serbo town, Jimma zone, south-west Ethiopia.
    Ketema T; Bacha K; Birhanu T; Petros B
    Malar J; 2009 Jul; 8():177. PubMed ID: 19642976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
    Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of artemether-lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia.
    Mekonnen SK; Medhin G; Berhe N; Clouse RM; Aseffa A
    Malar J; 2015 Aug; 14():317. PubMed ID: 26271736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy of anti-malarial drugs against clinical Plasmodium vivax malaria in Ethiopia: a systematic review and meta-analysis.
    Ketema T; Bacha K; Getahun K; Bassat Q
    Malar J; 2021 Dec; 20(1):483. PubMed ID: 34952581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of artemether-lumefantrine for Plasmodium vivax infections in a prospective study in Guyana.
    Eibach D; Ceron N; Krishnalall K; Carter K; Bonnot G; Bienvenu AL; Picot S
    Malar J; 2012 Oct; 11():347. PubMed ID: 23083017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil.
    Ladeia-Andrade S; Menezes MJ; de Sousa TN; Silvino ACR; de Carvalho JF; Salla LC; Nery OA; de Melo GNP; Corder RM; Rodrigues PT; Ferreira MU
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010.
    Congpuon K; Satimai W; Sujariyakul A; Intanakom S; Harnpitakpong W; Pranuth Y; Cholpol S; Bualombai P
    J Vector Borne Dis; 2011 Dec; 48(4):190-6. PubMed ID: 22297279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.